Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?

Kidney Int. 2004 Mar;65(3):1105-6. doi: 10.1111/j.1523-1755.2004.00527.x.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • AIDS-Associated Nephropathy / drug therapy*
  • AIDS-Associated Nephropathy / metabolism*
  • Animals
  • Antiretroviral Therapy, Highly Active*
  • HIV Protease Inhibitors / pharmacology*
  • Humans
  • Oxidative Stress / drug effects*

Substances

  • HIV Protease Inhibitors